[THE NATIONAL CENTRE FOR ONCOLOGY HADRONTHERAPY (CNAO): STATUS AND PERSPECTIVES]
Abstract
A complex particle accelerator has been built at the Italian National Centre for Oncological Adrotherapy in Pavia, called synchrotron, which is able to decompose atoms and create beams of particles to be directed to tumour cells in order to destroy them. It is the hadrontherapy, a very advanced radiation therapy for the treatment of X-ray resistant or inoperable tumours. In particular, the CNAO synchrotron in Pavia is the only one in Italy capable of extracting carbon ions from the atom, which are the most powerful particles capable of destroying the DNA of cancer cells while preserving the surrounding healthy tissues. Hadrontherapy has been recently included by the Italian Ministry of Health into the essential levels of assistance, recognizing its scientific validity. All Italian citizens can access treatments within the National Health System, according to defined modalities. More than 50 patients are treated at CNAO every day and to date more than 2300 cancer patients from all over Italy have been able to benefit from hadrontherapy.
The article will illustrate the technological innovation of the centre in Pavia and will focus on the most interesting research and development projects.
References
- 1) Wilson R.R., Radiology 1946; 47:487. DOI: https://doi.org/10.1148/47.5.487
- 2) www.ptcog.ch 3) Gruppo di Studio sulle Radiazioni con Adroni, Pubblicazione AIRO, 30 settembre 2003.
- 4) Rossi S. The Status of CNAO. Eur Phys J Plus 2011; 126: 78. 5) Rossi S. The National Centre for Oncological Hadrontherapy (CNAO): status and perspectives. Physica Medica 2015; 31: 333-351. DOI: https://doi.org/10.1016/j.ejmp.2015.03.001
- 6) Nedunchezhian K, et al. Boron Neutron Capture Therapy - A literature review. Journal of Clinical Diagnostics Research 2016 Dec; Vol-10(12): 2E01-2E04.
- 7) Barth R, et al. A realistic appraisal of Boron Neutron Capture Therapy as a cancer treatment modality. Cancer Commun 2018; 38: 36. DOI: https://doi.org/10.1186/s40880-018-0280-5
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2020 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.